B. W. Senior

2.2k total citations
64 papers, 1.6k citations indexed

About

B. W. Senior is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, B. W. Senior has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Microbiology and 13 papers in Immunology. Recurrent topics in B. W. Senior's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Bacteriophages and microbial interactions (10 papers) and Escherichia coli research studies (9 papers). B. W. Senior is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Bacteriophages and microbial interactions (10 papers) and Escherichia coli research studies (9 papers). B. W. Senior collaborates with scholars based in United Kingdom, Denmark and Hungary. B. W. Senior's co-authors include Michael A. Kerr, I. Barry Holland, L.M. Loomes, Jenny M. Woof, Colin Hughes, Michael Cross, Eva Koronakis, Vassilis Koronakis, D. C. Old and M. Albrechtsen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Molecular Biology.

In The Last Decade

B. W. Senior

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. W. Senior United Kingdom 25 564 394 294 236 224 64 1.6k
Martha Grout United States 22 1.3k 2.3× 422 1.1× 240 0.8× 299 1.3× 515 2.3× 23 2.4k
Nicola J. High United Kingdom 15 623 1.1× 416 1.1× 226 0.8× 161 0.7× 63 0.3× 19 1.5k
Jean-Claude Piffaretti Switzerland 25 534 0.9× 260 0.7× 613 2.1× 247 1.0× 240 1.1× 55 3.2k
J. Glenn Songer United States 23 427 0.8× 270 0.7× 214 0.7× 144 0.6× 66 0.3× 40 1.8k
B U von Specht Germany 21 362 0.6× 139 0.4× 245 0.8× 185 0.8× 227 1.0× 35 1.1k
D Olive France 26 778 1.4× 278 0.7× 1.0k 3.6× 251 1.1× 105 0.5× 90 3.1k
Michael Lebens Sweden 27 528 0.9× 826 2.1× 756 2.6× 253 1.1× 114 0.5× 63 2.0k
A Labigne France 26 618 1.1× 793 2.0× 1.1k 3.6× 334 1.4× 215 1.0× 41 3.4k
Leslie D. Cope United States 29 712 1.3× 273 0.7× 236 0.8× 397 1.7× 322 1.4× 48 2.4k
J. Häcker Germany 28 1.3k 2.3× 1.3k 3.3× 428 1.5× 399 1.7× 297 1.3× 60 2.5k

Countries citing papers authored by B. W. Senior

Since Specialization
Citations

This map shows the geographic impact of B. W. Senior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. W. Senior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. W. Senior more than expected).

Fields of papers citing papers by B. W. Senior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. W. Senior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. W. Senior. The network helps show where B. W. Senior may publish in the future.

Co-authorship network of co-authors of B. W. Senior

This figure shows the co-authorship network connecting the top 25 collaborators of B. W. Senior. A scholar is included among the top collaborators of B. W. Senior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. W. Senior. B. W. Senior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Senior, B. W. & Jenny M. Woof. (2006). Sites in the CH3 Domain of Human IgA1 That Influence Sensitivity to Bacterial IgA1 Proteases. The Journal of Immunology. 177(6). 3913–3919. 16 indexed citations
2.
Almogren, Ahmad, B. W. Senior, & Michael A. Kerr. (2006). A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S‐IgA1 and S‐IgA2. Immunology. 120(2). 273–280. 24 indexed citations
3.
Senior, B. W. & Jenny M. Woof. (2005). The Influences of Hinge Length and Composition on the Susceptibility of Human IgA to Cleavage by Diverse Bacterial IgA1 Proteases. The Journal of Immunology. 174(12). 7792–7799. 41 indexed citations
5.
Tavakoli, Manouche, et al.. (1999). Decision Analysis of Histamine H2-Receptor Antagonist Maintenance Therapy Versus Helicobacter pylori Eradication Therapy. PharmacoEconomics. 16(4). 355–365. 14 indexed citations
6.
Malek, M., et al.. (1998). H2‐antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Alimentary Pharmacology & Therapeutics. 12(9). 873–880. 15 indexed citations
7.
Wilson, CR, B. W. Senior, Harmale Tiwana, Wilson Caparrós‐Wanderley, & Alan Ebringer. (1998). Antibiotic sensitivity and proticine typing of Proteus mirabilis strains associated with rheumatoid arthritis. Rheumatology International. 17(5). 203–205. 8 indexed citations
8.
Senior, B. W.. (1997). Media for the Detection and Recognition of the Enteropathogen Providencia Alcalifaciens in Faeces. Journal of Medical Microbiology. 46(6). 524–527. 13 indexed citations
9.
Senior, B. W.. (1997). The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type. Journal of Medical Microbiology. 46(5). 407–412. 2 indexed citations
10.
Senior, B. W., et al.. (1995). The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. Journal of Medical Microbiology. 43(3). 176–184. 25 indexed citations
11.
Senior, B. W.. (1993). The production of HlyA toxin by Proteus penneri strains. Journal of Medical Microbiology. 39(4). 282–289. 10 indexed citations
12.
Loomes, L.M., Michael A. Kerr, & B. W. Senior. (1993). The cleavage of immunoglobulin G in vitro and in vivo by a proteinase secreted by the urinary tract pathogen Proteus mirabilis. Journal of Medical Microbiology. 39(3). 225–232. 18 indexed citations
13.
Senior, B. W., L.M. Loomes, & Michael A. Kerr. (1991). The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. Journal of Medical Microbiology. 35(4). 203–207. 35 indexed citations
14.
Senior, B. W., et al.. (1990). Protein profile typing--a new method of typing Morganella morganii strains. Journal of Medical Microbiology. 33(4). 259–264. 10 indexed citations
15.
Senior, B. W., et al.. (1989). A novel fimbrial haemagglutinin produced by a strain ofSalmonellaof serotype Salinatis. FEMS Microbiology Letters. 57(1). 29–34. 5 indexed citations
16.
Old, D. C., et al.. (1989). Characterisation of a Fimbrial, Mannose-Resistant and Eluting Haemagglutinin (MREHA) Produced by Strains of Salmonella of Serotype Sendai. Journal of Medical Microbiology. 30(1). 59–68. 3 indexed citations
18.
Old, D. C., et al.. (1989). The haemagglutinins and fimbriae of Proteus penneri. Journal of Medical Microbiology. 30(4). 279–284. 17 indexed citations
19.
Senior, B. W. & Colin Hughes. (1988). Production and properties of haemolysins from clinical isolates of the Proteeae. Journal of Medical Microbiology. 25(1). 17–25. 21 indexed citations
20.
Richardson, Hugh H., et al.. (1968). Agar Diffusion Method for the Assay of Colicins. Applied Microbiology. 16(10). 1468–1474. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026